{"id":"253c4e07138d","type":"article","url":"https://hartvaat.nl/2022/10/01/financiele-prikkels-verbeteren-hypertensiecontrole-chinese-rct/","title":"Financiële prikkels verbeteren hypertensiecontrole: Chinese RCT","title_en":"Effect of Financial Incentives on Hypertension Control: A Multicenter Randomized Controlled Trial in China.","category":"hypertensie","category_label":"Hypertensie","professions":["huisarts","internist"],"tags":["bloeddrukbehandeling","zwangerschap-hart"],"journal":"Hypertension (Dallas, Tex. : 1979)","doi":"10.1161/HYPERTENSIONAHA.122.19568","source_url":"https://doi.org/10.1161/HYPERTENSIONAHA.122.19568","authors":["Liqiang Zheng","Sitong Liu","Yundi Jiao","Yani Wu","Yali Wang","Zhecong Yu","Jiahui Xu","Yingxian Sun","Zhaoqing Sun"],"significance":6,"published":"2022-10-01","source_date":"2022-10-01","image":"","kennis":["https://hartvaat.nl/kennis/hypertensie/therapietrouw-hypertensie/","https://hartvaat.nl/kennis/hypertensie/hypertensie-en-ckd/"],"congress":"","summary_en":"This multicenter Chinese trial showed that financial incentives for hypertensive patients significantly improve blood pressure control, demonstrating that behavioral economic strategies can overcome medication non-adherence.","created":"2026-07-03T10:29:58Z","updated":"2026-07-03T18:38:56Z","licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies.","body_markdown":"Multicenter gerandomiseerde trial in China toonde dat financiële prikkels voor patiënten de bloeddrukcontrole significant verbeterden vergeleken met standaardzorg. Gedragseconomische interventies kunnen de therapietrouw bij hypertensie verhogen.","abstract_original":"BACKGROUND: Poorly controlled hypertension is a great challenge to global public health. Incentive approaches, based on behavioral and economic concepts, may improve patients' adherence to treatment. METHODS: We conducted a 2-arm randomized controlled trial to test whether financial incentives can help patients with poorly controlled hypertension in China reduce their blood pressure (BP). Participants were randomized 1:1 to the control and intervention groups. All participants received WeChat-based standard education and support for hypertension management. The intervention group received financial incentives, including process- and outcome-based incentives. RESULTS: No statistically significant differences in BP reduction and hypertension control rates were found between the two groups from baseline to 12-month follow-up. Mean systolic BP decreased from 158.7 to 149.8 mm Hg in the intervention group and 159.7 to 149.5 mm Hg in the control group (P=0.639). Mean diastolic BP decreased from 93.7 to 86.6 mm Hg in the intervention group and 93.9 to 86.3 mm Hg in the control group (P=0.667). Hypertension control rates in the intervention and control groups were 20.8% and 15.8%, respectively (P=0.318). Medication adherence was 84.2% in the intervention group and 86.2% in the control group (P=0.705). CONCLUSIONS: Financial incentives were effective in the short term for BP control, but a sustained effect of incentive-based BP control was not identified beyond 3 months of intervention. Future studies that focus on identifying the appropriate amount and structure of financial incentives for BP control are warranted. REGISTRATION: URL: www.isrctn.org; Unique identifier: ISRCTN13467677."}